Finance

Lists
NAV:CVE
Navco Pharmaceuticals Inc
0,0050 CA$
0,00%
(0,00) 1D
24 қыр., 13:45:09 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NAV...
Mkt. cap
285,35 м.
Avg. vol.
897,00
Volume
0,00
52-wk high
0,01 CA$
52-wk low
0,00 CA$
EPS
-0,00 CA$
Beta
13,69
Shares outstanding
57,07 млн
Mkt. cap
285,35 м.
Avg. vol.
897,00
Volume
0,00
52-wk high
0,01 CA$
52-wk low
0,00 CA$
EPS
-0,00 CA$
Beta
13,69
Shares outstanding
57,07 млн
News stories
From web sources and news partners
About Navco Pharmaceuticals Inc
CEO-
Employees-
Founded-
HeadquartersВанкувер, Британдық Колумбия, Канада
Sector-
Websitenavcopharma.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34,77 мың
2,06 мың
2,95 мың
1,58 мың
Operating expense
34,77 мың
2,06 мың
2,95 мың
1,58 мың
Total operating expenses
34,77 мың
2,06 мың
2,95 мың
1,58 мың
Operating income
-34,77 мың
-2,06 мың
-2,95 мың
-1,58 мың
Other non operating income
-2,27 мың
-1,16 мың
-10,54 мың
-1,91 мың
EBT including unusual items
-39,64 мың
-5,83 мың
-16,55 мың
-6,82 мың
EBT excluding unusual items
-39,64 мың
-5,83 мың
-16,55 мың
-6,82 мың
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-39,64 мың
-5,83 мың
-16,55 мың
-6,82 мың
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2,61 мың
-2,61 мың
-3,06 мың
-3,33 мың
Net interest expenses
-2,61 мың
-2,61 мың
-3,06 мың
-3,33 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-26,38 мың
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары